))
A Second Opinion – “Risk/Benefit Ratio: Is the Cure Worth the Kill?”
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on August 02, 2024 04:09 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 309008730 series 3025226
Inhoud geleverd door A Second Opinion Archives - WebTalkRadio.net. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door A Second Opinion Archives - WebTalkRadio.net of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Host TS Wiley interviews mainstream oncologist Julie Taguchi from Sansum Clinic in Santa Barbara, California on the memory loss attendant with estrogen deprivation and chemotherapy. In the interview they also cover the validity of big pharma testing on oncology drugs versus no treatment at all. This is a candid and frank interview with someone on the inside of the standard of care in breast cancer treatment. This isn’t a show you want to miss!
The post A Second Opinion – “Risk/Benefit Ratio: Is the Cure Worth the Kill?” appeared first on WebTalkRadio.net.
20 afleveringen
Delen
